Colgate-Palmolive Co logo

Colgate-Palmolive Co (CL)

Market Closed
24 Feb, 20:00
NYSE NYSE
$
98. 11
+1.01
+1.04%
$
76.65B Market Cap
40.3 P/E Ratio
2% Div Yield
5,404,297 Volume
3.21 Eps
$ 97.1
Previous Close
Day Range
96.42 98.2
Year Range
74.55 100.18
Want to track CL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CL earnings report is expected in 57 days (23 Apr 2026)
7 Defensive Stocks to Buy as Investors Seek Shelter

7 Defensive Stocks to Buy as Investors Seek Shelter

Although the market may have hit a calm relative to the wild volatility witnessed earlier this month, we may not be out of the woods yet. Sure, the CBOE Volatility Index or the VIX has come down significantly from its earlier highs.

Investorplace | 1 year ago
7 Divine Dividend Stocks to Buy for Another Market Crash

7 Divine Dividend Stocks to Buy for Another Market Crash

Buying dividend stocks has proven to be a superior investing strategy. Because dividend payers tend to be large, successful businesses, they can better withstand the winds of market turmoil.

Investorplace | 1 year ago
4 Consumer Staples Stocks to Buy Amid Wall Street Bloodbath

4 Consumer Staples Stocks to Buy Amid Wall Street Bloodbath

Consumer staple stocks like Colgate-Palmolive Company (CL), Kimberly-Clark Corporation (KMB), The Coca-Cola Company (KO) and Philip Morris International Inc. (PM) are a safe bet during times of market volatility.

Zacks | 1 year ago
Colgate-Palmolive: Good Growth Prospects Ahead

Colgate-Palmolive: Good Growth Prospects Ahead

Colgate-Palmolive Company has good growth prospects with revenue growth expected from price increases, especially in emerging markets and Hills Pet Nutrition business. The company's margins should benefit from a favorable price/cost environment, volume leverage, and cost-saving initiatives, leading to continued growth and a healthy dividend yield. Despite a 30% stock price increase, Colgate's strong earnings growth and potential for further upside make it a buy with high single-digit EPS growth expected.

Seekingalpha | 1 year ago
Is Colgate-Palmolive (CL) a Solid Growth Stock? 3 Reasons to Think "Yes"

Is Colgate-Palmolive (CL) a Solid Growth Stock? 3 Reasons to Think "Yes"

Colgate-Palmolive (CL) could produce exceptional returns because of its solid growth attributes.

Zacks | 1 year ago
Are Consumer Staples Stocks Lagging ColgatePalmolive (CL) This Year?

Are Consumer Staples Stocks Lagging ColgatePalmolive (CL) This Year?

Here is how Colgate-Palmolive (CL) and Ollie's Bargain Outlet (OLLI) have performed compared to their sector so far this year.

Zacks | 1 year ago
Colgate (CL) Stock Gains on Q2 Earnings Beat, '24 EPS View Hike

Colgate (CL) Stock Gains on Q2 Earnings Beat, '24 EPS View Hike

Colgate's (CL) Q2 results reflect continued gains in volume and pricing, offset by greater negative impacts of currency, leading to robust organic sales growth. CL raises the adjusted EPS view for 2024.

Zacks | 1 year ago
Are You Looking for a High-Growth Dividend Stock?

Are You Looking for a High-Growth Dividend Stock?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes?

Zacks | 1 year ago
Colgate-Palmolive Stock Is Jumping as Its Earnings, Outlook Impressed

Colgate-Palmolive Stock Is Jumping as Its Earnings, Outlook Impressed

Colgate-Palmolive Company (CL) beat expectations on the top and bottom lines with its second-quarter results Friday, sending its shares toward record highs.

Investopedia | 1 year ago
Colgate-Palmolive (CL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Colgate-Palmolive (CL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Colgate-Palmolive (CL) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 1 year ago
Colgate-Palmolive (CL) Surpasses Q2 Earnings and Revenue Estimates

Colgate-Palmolive (CL) Surpasses Q2 Earnings and Revenue Estimates

Colgate-Palmolive (CL) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.87 per share. This compares to earnings of $0.77 per share a year ago.

Zacks | 1 year ago
Colgate-Palmolive raises 2024 forecasts on strong demand

Colgate-Palmolive raises 2024 forecasts on strong demand

Toothpaste maker Colgate-Palmolive raised its forecasts for annual profit and organic sales on Friday, after beating second-quarter estimates on resilient demand for its high-priced products.

Reuters | 1 year ago
Loading...
Load More